Hypomagnesemia is a reliable predictor for efficacy of anti-EGFR monoclonal antibody used in combination with first-line chemotherapy for metastatic colorectal cancer.
第一作者:
Hironori,Fujii
第一单位:
Department of Pharmacy, Gifu University Hospital, Gifu, 501-1194, Japan. h_fujii@gifu-u.ac.jp.
作者:
主题词
痤疮样疹(Acneiform Eruptions);老年人(Aged);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);结直肠肿瘤(Colorectal Neoplasms);女(雌)性(Female);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);镁(Magnesium);男(雄)性(Male);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);试验预期值(Predictive Value of Tests);治疗失败(Treatment Failure)
DOI
10.1007/s00280-016-3039-1
PMID
27106835
发布时间
2018-12-02
- 浏览82
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文